TLC BioSciences Corp. (TPEX:7924)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
195.50
-15.00 (-7.13%)
At close: Jul 29, 2026

TLC BioSciences Statistics

Total Valuation

TLC BioSciences has a market cap or net worth of TWD 28.85 billion. The enterprise value is 29.11 billion.

Market Cap28.85B
Enterprise Value 29.11B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

TLC BioSciences has 133.56 million shares outstanding.

Current Share Class 133.56M
Shares Outstanding 133.56M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 24.45%
Owned by Institutions (%) n/a
Float 88.80M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 322.56
PB Ratio -7.84
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.18

Current Ratio 0.18
Quick Ratio 0.14
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.06
Interest Coverage -5.07

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -21.30%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 17.76%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.05
Inventory Turnover 0.30

Taxes

In the past 12 months, TLC BioSciences has paid 4.61 million in taxes.

Income Tax 4.61M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 48.38
Average Volume (20 Days) 298,330

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TLC BioSciences had revenue of TWD 89.44 million and -653.25 million in losses. Loss per share was -7.84.

Revenue89.44M
Gross Profit 73.93M
Operating Income -639.05M
Pretax Income -648.64M
Net Income -653.25M
EBITDA -571.17M
EBIT -639.05M
Loss Per Share -7.84
Full Income Statement

Balance Sheet

The company has 694.74 million in cash and 955.97 million in debt, with a net cash position of -261.23 million or -1.96 per share.

Cash & Cash Equivalents 694.74M
Total Debt 955.97M
Net Cash -261.23M
Net Cash Per Share -1.96
Equity (Book Value) -3.68B
Book Value Per Share -44.16
Working Capital -4.17B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -347.17 million and capital expenditures -117.83 million, giving a free cash flow of -464.99 million.

Operating Cash Flow -347.17M
Capital Expenditures -117.83M
Depreciation & Amortization 67.88M
Net Borrowing -52.79M
Free Cash Flow -464.99M
FCF Per Share -3.48
Full Cash Flow Statement

Margins

Gross Margin 82.66%
Operating Margin -714.51%
Pretax Margin -725.24%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TLC BioSciences does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -2.26%
FCF Yield -1.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TLC BioSciences has an Altman Z-Score of -16.9 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.9
Piotroski F-Score 1